These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19925734)

  • 1. [Stem cell harvesting after plerixafor treatment].
    Hansen PB; Gaarsdal E
    Ugeskr Laeger; 2009 Nov; 171(47):3452-3. PubMed ID: 19925734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
    Worel N; Rosskopf K; Neumeister P; Kasparu H; Nachbaur D; Russ G; Namberger K; Witt V; Schloegl E; Zojer N; Linkesch W; Kalhs P; Greinix HT
    Transfusion; 2011 May; 51(5):968-75. PubMed ID: 20880037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.
    Andreola G; Babic A; Rabascio C; Negri M; Martinelli G; Laszlo D
    Eur J Haematol; 2012 Feb; 88(2):154-8. PubMed ID: 21992403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment.
    Sevilla J; Schiavello E; Madero L; Pardeo M; Guggiari E; Baragaño M; Luksch R; Massimino M
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):146-50. PubMed ID: 22009006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plerixafor as first- and second-line strategies for autologous stem cell mobilization in patients with non-Hodgkin's lymphoma or multiple myeloma.
    Lor KW; Helmons PJ; Belew H; Lane JR; Ball ED
    Pharmacotherapy; 2012 Jul; 32(7):596-603. PubMed ID: 22760691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.
    DiPersio JF; Micallef IN; Stiff PJ; Bolwell BJ; Maziarz RT; Jacobsen E; Nademanee A; McCarty J; Bridger G; Calandra G;
    J Clin Oncol; 2009 Oct; 27(28):4767-73. PubMed ID: 19720922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mobilisation of haematopoietic stem cells with plerixafor--secondary publication].
    Hansen PB; Gaarsdal E
    Ugeskr Laeger; 2009 Nov; 171(45):3272-5. PubMed ID: 19887056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomes.
    Perkins JB; Shapiro JF; Bookout RN; Yee GC; Anasetti C; Janssen WE; Fernandez HF
    Am J Hematol; 2012 Jul; 87(7):673-7. PubMed ID: 22674468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
    Bhamidipati PK; Fiala MA; Grossman BJ; DiPersio JF; Stockerl-Goldstein K; Gao F; Uy GL; Westervelt P; Schroeder MA; Cashen AF; Abboud CN; Vij R
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2065-2069. PubMed ID: 28797783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of Hematopoietic Stem Cells for Hematopoietic Cells Autologous Transplantation with Use of Plerixafor.
    Gawroński K; Rzepecki P; Sawicki W; Wajs J
    Ann Transplant; 2017 May; 22():296-302. PubMed ID: 28496091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation.
    Flomenberg N; Comenzo RL; Badel K; Calandra G
    Biol Blood Marrow Transplant; 2010 May; 16(5):695-700. PubMed ID: 20067838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plerixafor: what we still have to learn.
    Lanza F; Gardellini A; Laszlo D; Martino M
    Expert Opin Biol Ther; 2015 Feb; 15(2):143-7. PubMed ID: 25315706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined plerixafor and granulocyte colony-stimulating factor for harvesting high-dose hematopoietic stem cells: Possible niche for plerixafor use in pediatric patients.
    Bitan M; Eshel R; Sadot E; Friedman S; Pinhasov A; Levin D; Dvir R; Manisterski M; Berger-Achituv S; Rosenfeld-Keidar H; Elhasid R
    Pediatr Transplant; 2016 Jun; 20(4):565-71. PubMed ID: 26991903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.
    Stover JT; Shaw JR; Kuchibhatla M; Horwitz ME; Engemann AM
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1290-1294. PubMed ID: 28411174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study.
    Zhu J; Huang H; Chen H; Zhang X; Li Z; Wu D; Zhou D; Song Y; Hu Y; Liang Y; Ren H; Huang H; Li N; Chen H; Hu J; Li J; Meng R; Wu J; Yu D; Huang X
    Transfusion; 2018 Jan; 58(1):81-87. PubMed ID: 29238988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation.
    Narayanasami U; Kanteti R; Morelli J; Klekar A; Al-Olama A; Keating C; O'Connor C; Berkman E; Erban JK; Sprague KA; Miller KB; Schenkein DP
    Blood; 2001 Oct; 98(7):2059-64. PubMed ID: 11567990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.
    Duarte RF; Shaw BE; Marín P; Kottaridis P; Ortiz M; Morante C; Delgado J; Gayoso J; Goterriz R; Martínez-Chamorro C; Mateos-Mazón JJ; Ramírez C; de la Rubia J; Achtereekte H; Gandhi PJ; Douglas KW; Russell NH
    Bone Marrow Transplant; 2011 Jan; 46(1):52-8. PubMed ID: 20305700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is autologous progenitor cell mobilization getting any easier?
    Litzow MR
    Leuk Lymphoma; 2007 Dec; 48(12):2304-5. PubMed ID: 18067002
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor.
    Varmavuo V; Mäntymaa P; Kuittinen T; Nousiainen T; Jantunen E
    Transfusion; 2012 Aug; 52(8):1785-91. PubMed ID: 22304442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma.
    Hundemer M; Engelhardt M; Bruckner T; Kraeker S; Schmitt A; Sauer S; Neben K; Witzens-Harig M; Goldschmidt H; Ho AD; Wuchter P
    J Clin Apher; 2014 Dec; 29(6):299-304. PubMed ID: 24771277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.